For: | Zhu HS, Li D, Li C, Huang JX, Chen SS, Li LB, Shi Q, Ju XL. Prior transfusion of umbilical cord mesenchymal stem cells can effectively alleviate symptoms of motion sickness in mice through interleukin 10 secretion. World J Stem Cells 2021; 13(2): 177-192 [PMID: 33708346 DOI: 10.4252/wjSC.v13.i2.177] |
---|---|
URL: | https://www.wjgnet.com/1948-0210/full/v13/i2/177.htm |
Number | Citing Articles |
1 |
Tianhao Yu, Aijun Wang, Qiang Ao. Editorial: New exploration for therapeutic tissue engineering grafts in the field of tissue regeneration. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1256907
|
2 |
Xinnan Chen, Ying Jiang, Haohao Zhu, Man Tian. Mining and evaluation of adverse event signals for capmatinib based on the FAERS database. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1417661
|
3 |
Na Dong, Pan-Pan Zhou, Dong Li, Hua-Su Zhu, Ling-Hong Liu, Hui-Xian Ma, Qing Shi, Xiu-Li Ju. Intratracheal administration of umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced multi-organ injury <i>via </i>heme oxygenase-1 and JAK/STAT pathways. World Journal of Stem Cells 2022; 14(7): 556-576 doi: 10.4252/wjsc.v14.i7.556
|